Nuveen, LLC 4 D Molecular Therapeutics, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 150,314 shares of FDMT stock, worth $515,577. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150,314Holding current value
$515,577% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FDMT
# of Institutions
133Shares Held
47.4MCall Options Held
121KPut Options Held
33.2K-
Black Rock Inc. New York, NY4.9MShares$16.8 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.56MShares$15.7 Million0.41% of portfolio
-
Goldman Sachs Group Inc New York, NY4.17MShares$14.3 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.95MShares$10.1 Million2.71% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.76MShares$9.46 Million0.0% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $111M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...